[TCM] Resolution on Lifting Non-Compete Restrictions for Directors at the 2026 Annual General Shareholders' Meeting
NQ Score
63/100
N1 Content Completeness
10
AI Summary (NQ-processed)
TCM Biotech announced that at its 2026 Annual General Shareholders' Meeting held on June 5, it passed a resolution to lift non-compete restrictions for all its directors and independent directors.
AI Analysis
Frequently Asked Questions
- Q: What is the recent announcement from TCM Biotech?
- A: During the shareholders' meeting on June 5, 2026, it was decided to lift non-compete restrictions for all directors.
- Q: What is the purpose of this decision?
- A: To allow directors to hold concurrent positions at other companies and ensure flexible management.
- Q: Which directors are affected?
- A: All eight directors: Hsu Huan-Ching, Chen Tzu-Pei, Chen Chin-Chi, Wang Ya-Chun, Hsu Yi-Fang, Kuo Cheng-Hung, Chen Hui-Yu, and Liu Heng-Yi.